Abstract
Background Recurrent respiratory tract infections (rRTIs) are a common reason for immunodiagnostic testing in children, which relies on serum antibody level measurements. However, because RTIs predominantly affect the respiratory mucosa, serum antibodies may inaccurately reflect local immune defences. We investigated antibody responses in saliva and their interplay with the respiratory microbiota in relation to RTI severity and burden in young children with rRTIs. Methods We conducted a prospective cohort study including 100 children aged <10 years with rRTIs, their family members and healthy healthcare professionals. Total and polyreactive antibody concentrations were determined in serum and saliva (ELISA); respiratory microbiota composition (16S rRNA sequencing) and respiratory viruses (quantitative PCR) were characterised in nasopharyngeal swabs. Proteomic analysis (Olink) was performed on saliva and serum samples. RTI symptoms were monitored with a daily mobile phone application and assessed using latent class analysis and negative binomial mixed models. Results Serum antibody levels were not associated with RTI severity. Strikingly, 28% of salivary antibodies and only 2% of serum antibodies displayed polyreactivity (p<0.001). Salivary polyreactive IgA was negatively associated with recurrent lower RTIs (adjusted OR 0.80, 95% CI 0.67-0.94) and detection of multiple respiratory viruses (adjusted OR 0.76, 95% CI 0.61-0.96). Haemophilus influenzae abundance was positively associated with RTI symptom burden (regression coefficient 0.05, 95% CI 0.02-0.08). Conclusion These results highlight the importance of mucosal immunity in RTI severity and burden, and suggest that the level of salivary polyreactive IgA and H. influenzae abundance may serve as indicators of infection severity and burden in young children with rRTIs.
Original language | English |
---|---|
Article number | e2400317 |
Number of pages | 18 |
Journal | European Respiratory Journal |
Volume | 64 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Oct 2024 |
Bibliographical note
Publisher Copyright:© The authors 2024.
Funding
Support statement: The DIMER study was funded by the Wilhelmina Children\u2019s Hospital Research Fund and the \u201CChristine Bader Stichting Irene KinderZiekenhuis\u201D. L.M. Verhagen is financially supported by an ESPID Fellowship funded by Seqirus, a Hypatia Fellowship funded by the Radboud University Medical Centre and by The Netherlands Organisation for Health Research and Development (ZonMW VENI grant number 09150162010077). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Funding information for this article has been deposited with the Crossref Funder Registry.
Funders | Funder number |
---|---|
Radboud Universitair Medisch Centrum | |
Wilhelmina Children’s Hospital Research Fund | |
ZonMw | 09150162010077 |